Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis ARTEMISMED

Max Ratio

Dividend Yield

0.34 %

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

1 820 351.78 %

Dividend History ARTEMISMED

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 0.34 %
Consecutive Years 0
Forward Annual Dividend 0.90 INR
Consistent Years 2
Dividend CAGR 3Y -98.17 %
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM 8.15 %
Dividend CAGR 10Y
Ex Dividend Date 07/11/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth ARTEMISMED

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin ARTEMISMED

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income ARTEMISMED

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM ARTEMISMED

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio ARTEMISMED

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Artemis Medicare Services Limited ARTEMISMED

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself ARTEMISMED

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 117.49
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA
Price Book MRQ

Artemis Medicare Services Limited Dividends: 0.17 % Yield, History, Payment Schedule

ARTEMISMED
Current price
266.10 INR -3.94 INR (-1.46%)
Last closed 271.20 INR
ISIN INE025R01021
Sector Other
Industry Other
Exchange National Stock Exchange of India
Capitalization
Yield for 12 month -20.92 %
1Y
3Y
5Y
10Y
15Y
ARTEMISMED
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+9 384 898 593 INR

Last Year

+8 800 495 006 INR

Current Quarter

+2 553 889 984 INR

Last Quarter

+2 403 029 131 INR

Current Year

+2 237 031 870 INR

Last Year

+1 778 694 570 INR

Current Quarter

+593 922 599 INR

Last Quarter

+549 344 818 INR
EBITDA 1 576 856 203 INR
Operating Margin TTM 14.16 %
Price to Earnings 117.49
Return On Assets TTM 5.46 %
PEG Ratio
Return On Equity TTM 11.23 %
Wall Street Target Price 27 680.44 INR
Revenue TTM 10 036 375 892 INR
Book Value 56.05 INR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 13.80 %
Dividend Yield 0.34 %
Gross Profit TTM 2 133 070 634 INR
Earnings per share 2.29 INR
Diluted Eps TTM 2.29 INR
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY 34.00 %
Profit Margin 9.48 %

Technical Indicators ARTEMISMED

For 52 Weeks

207.69 INR 349.96 INR
50 Day MA 253.85 INR
Shares Short Prior Month
200 Day MA 252.85 INR
Short Ratio
Shares Short
Short Percent